Other publications - Anna Castleton

List publications which are directly applicable to this grant and where LLR is acknowledged for funding – please note the impact factors of the journals:

The Role of Neutrophils in Measles Virus-mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF.

Dey A, Zhang Y, Castleton AZ, Bailey K, Beaton B, Patel B, Fielding AK.

Mol Ther. 2015 Aug 17. doi: 10.1038/mt.2015.149. Epub ahead of print.PMID: 26278331

Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology.

Patel B, Dey A, Castleton AZ, Schwab C, Samuel E, Sivakumaran J, Beaton B, Zareian N, Zhang CY, Rai L, Enver T, Moorman AV, Fielding AK.

Blood. 2014 Jul 3;124(1):96-105. doi: 10.1182/blood-2014-01-549352. Epub 2014 May 13. PMID:24825861.

Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity.

Castleton A, Dey A, Beaton B, Patel B, Aucher A, Davis DM, Fielding AK.

Blood. 2014 Feb 27;123(9):1327-35. doi: 10.1182/blood-2013-09-528851. Epub 2013 Dec 17. PMID:24345754

Accompanied by a (positive) commentary in the same issue of Blood: Oncolytic virotherapy for ALL: MSCs to the rescue Edwin M. HorwitzBlood. 2014 Feb 27;123(9):1286-7. doi: 10.1182/blood-2014-01-546747.

Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function.

Zhang Y, Patel B, Dey A, Ghorani E, Rai L, Elham M, Castleton AZ, Fielding AK.

J Immunol. 2012 Feb 1;188(3):1002-10. doi: 10.4049/jimmunol.1102262. Epub
2011 Dec 16

Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights.

Patel B, Dey A, Ghorani E, Kumar S, Malam Y, Rai L, Steele AJ, Thomson J,Wickremasinghe RG, Zhang Y, Castleton AZ, Fielding AK.

Mol Ther. 2011 Jun;19(6):1034-40. doi: 10.1038/mt.2011.44. Epub 2011 Mar 22. PMID: 21427708. Impact factor 6.82

Emerging Cancer Therapeutics: Adult Acute Lymphoblastic Leukaemia.

Anna Z. Castleton and Adele K. Fielding.

Published 08/2011. ISBN13 9781933864686

 

Last updated: October 2019

Christie stories during the COVID-19 pandemic

During the COVID-19 pandemic, we're doing all we can to make sure patients get the treatment, information and support they need. Read some stories from our patients and staff to find out what The Christie is doing at this difficult time.

View All
Corinne Faivre Finn
“We have seen a lot of our research staff return to the office. This has massively improved morale as it is a lot easier to connect with people.”
Corinne Faivre-Finn, Christie consultant
Read More
Read More
profile placeholder image
“The experience has allowed me to be able to hear what is not being said. The extraordinary strength and resilience of individuals as they greet you with a smile… when you are aware of the pain and anguish they will be going through.”
Digital services team, redeployed to telephone patients
Read More
Read More
“Of course, the COVID-19 virus has not gone away – we have to be cautious and we have to proceed in an appropriate way.”
Professor John Radford, director of research at The Christie
Read More
Read More